Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1496201 TEL AVIV, L3

Position in ORIC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,154,805
+$1,343,059 QoQ
Shares Held
752,983
+40.1% QoQ
Ownership
0.726%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#40
of 179 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORIC Over Time

Shares Held

Position Value (USD)

Derivatives in ORIC

reported options exposure · as of Jun 30, 2026
CallValue
$1,083,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. ORIC ranks #16 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORIC

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,154,805 752,983
2026-06-30 $1,083,000 100,000
2026-03-31 $6,811,746 537,628
2025-12-31 $8,215,812 1,004,378
2025-09-30 $5,180,316 431,693
2025-06-30 $4,006,133 394,693
2025-03-31 $1,310,373 234,834
2024-12-31 $2,204,828 273,213
2024-09-30 $1,316,059 128,396
2023-12-31 $1,166,560 126,800
2021-03-31 $4,162,550 169,900
2020-12-31 $6,167,470 182,200